✦ LIBER ✦

W1808 Regression of Fibrosis/Cirrhosis with Long-Term Entecavir Therapy in Chronic Hepatitis B (CHB) Patients with Baseline Bridging Fibrosis or Cirrhosis: Results from Studies ETV-022, -027 and -901

✍ Scribed by Schiff, Eugene R.; Lee, Samuel S.; Chao, You-Chen; Yoon, Seung-Kew; Bessone, Fernando O.; Wu, Shun-Sheng; Kryczka, Wieslaw; Lurie, Yoav; Gadano, Adrian; Kitis, George; Beebe, Suzanne; Kreter, Bruce; Xu, Dong; Harris, Melissa; Iloeje, Uchenna H.; Tang, Hong

Book ID: 122754908
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 148 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)63994-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

633 Histologic Improvement in Asian Pati

633 Histologic Improvement in Asian Patients With HBeAg(+) and HBeAg(−) Chronic Hepatitis B After Long-Term Treatment With Entecavir: Results From ETV-022, -027 and -901 Studies

✍ Tong, Myron J.; Chang, Ting-Tsung; Wu, Shun-Sheng; Han, Kwang-Hyub; Yoon, Seung 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Long-term entecavir therapy results in t

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

✍ Ting-Tsung Chang; Yun-Fan Liaw; Shun-Sheng Wu; Eugene Schiff; Kwang-Hyub Han; Ch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 679 KB

One year of treatment with entecavir (0.5 mg daily) in nucleoside-naive patients with hepatitis B e antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis B (CHB) resulted in significantly improved liver histology and virological and biochemical endpoints in comparison with lamivudine. Patient